Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term methylphenidate cardiovascular effects in adolescents and young adults with ADHD
NL-OMON37801Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Hypertension on 24-hour ambulatory blood pressure monitoring and Left ventricular hypertrophy by indexed left ventricular mass. Started Aug 2012; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON37801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37801.